• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00516910
Medical Device Problem Codes Use of Device Problem (1670); Migration (4003)
Health Effect - Clinical Code No Code Available (3191)
Date of Event 03/01/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Age or date of birth: patient's exact age is unknown; however it was reported that the patient was over the age of 18.Date of event: date of event was approximated to (b)(6) 2019 as no specific event date was reported.Lot #, manufacture date: the complainant was unable to provide the lot number.Therefore, the manufacture and expiration dates are unknown.(b)(4).The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported to boston scientific corporation on (b)(6) 2019 that a wallflex esophageal partially covered stent was implanted to seal a perforation in the distal esophagus during an esophagogastroduodenoscopy (egd) with stent placement procedure performed on (b)(6) 2019.According to the complainant, on an unknown date, the stent migrated distally and was confirmed during an imaging study.Reportedly, on (b)(6) 2019 the migrated stent was removed endoscopically and was replaced with another wallflex esophageal stent.There were no patient complications reported as a result of this event.Note: according to the complainant, the wallflex esophageal partially covered stent was placed to seal a perforation.However, per wallflex esophageal partially covered stent system directions for use, the stent is indicated for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistulas.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX ESOPHAGEAL
Common Device Name
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key8529115
Report Number3005099803-2019-02009
Device Sequence Number1928694
Product Code ESW
UDI-Device Identifier08714729765257
UDI-Public08714729765257
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K073266
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberM00516910
Device Catalogue Number1691
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/27/2019
Initial Report FDA Received Date04/18/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-